Stockscreener 앱 받기
25.82
0.78%
0.199
시간 외 거래:
25.82
0.0004
+0.00%
전일 마감가:
$25.62
열려 있는:
$25.695
하루 거래량:
4,486
Relative Volume:
0.33
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.39%
1개월 성능:
-3.98%
6개월 성능:
+0.31%
1년 성능:
-9.97%
1일 변동 폭
$25.68
$25.87
1주일 범위
$25.17
$25.98
52주 변동 폭
$20.01
$29.21
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
OZEM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
25.82 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
318.94 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
646.63 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
649.80 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
252.99 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
573.49 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf 주식(OZEM)의 최신 뉴스
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
How to Invest in GLP-1 Stocks - The Motley Fool
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - MSN
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
Inside Last Week's Wall Street Rally & Best-Performing ETF Areas - TradingView
5 Sector ETFs Up 10% Despite February's Market Slump - TradingView
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Roundhill Investments Surpasses $4 Billion AUM Milestone – Company Announcement - Financial Times
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Yahoo Finance
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Nasdaq
Where to Invest in Health Trends - Bloomberg.com
Top Themes in the First Half of 2024: Crypto, Chips, Ships & Silver - ETF Trends
Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"? - 富途牛牛
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Weight-loss ETFs demand some heavy thinking - Financial Times
Wall Street issuer creates “Lucky 8” Chinese giant ETF to target the “Seven Heroes” of US stock technology - 富途牛牛
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - TradingView
OZEM, Weight Loss Drug ETFs: Should You Invest? - ETF.com
Did South Park mark the top for weight-loss stocks? - Sherwood News
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - Benzinga
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM) - Stock Titan
Fund Files: Eaton Vance, Voya PMs to depart; Roundhill launches active weight loss ETF - Citywire
Roundhill names new CEO - Citywire Professional Buyer
CHAT Stock Price | Roundhill Generative AI & Technology ETF - Investing.com
Roundhill Glp 1 Weight Loss Etf (OZEM) 재무 분석
Roundhill Glp 1 Weight Loss Etf (OZEM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.30%
0.24%
자본화:
|
볼륨(24시간):